Clinical Value of a 51-Neuroendocrine Tumor-Specific Gene Signature (NETest 2.0) for Management of Pancreatic and Small Bowel Neuroendocrine Tumors: A Prospective Study in a Consecutive Cohort of 82 Patients Considered for Surgery.

Frilling A, Clift A, Spalding D, Drymousis P, von Roon A, Goldin R, Bomanji J, Wasa H, Halim AB, Kidd M

Open source

DOI
10.1097/as9.0000000000000700
Published
2026 Sep
Container
Annals of surgery open : perspectives of surgical history, education, and clinical approaches
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/as9.0000000000000700,
  title = {Clinical Value of a 51-Neuroendocrine Tumor-Specific Gene Signature (NETest 2.0) for Management of Pancreatic and Small Bowel Neuroendocrine Tumors: A Prospective Study in a Consecutive Cohort of 82 Patients Considered for Surgery.},
  author = {Frilling A and Clift A and Spalding D and Drymousis P and von Roon A and Goldin R and Bomanji J and Wasa H and Halim AB and Kidd M},
  year = {2026},
  journal = {Annals of surgery open : perspectives of surgical history, education, and clinical approaches},
  doi = {10.1097/as9.0000000000000700},
  url = {https://doi.org/10.1097/as9.0000000000000700}
}

RIS

TY  - JOUR
TI  - Clinical Value of a 51-Neuroendocrine Tumor-Specific Gene Signature (NETest 2.0) for Management of Pancreatic and Small Bowel Neuroendocrine Tumors: A Prospective Study in a Consecutive Cohort of 82 Patients Considered for Surgery.
AU  - Frilling A
AU  - Clift A
AU  - Spalding D
AU  - Drymousis P
AU  - von Roon A
AU  - Goldin R
AU  - Bomanji J
AU  - Wasa H
AU  - Halim AB
AU  - Kidd M
PY  - 2026
JO  - Annals of surgery open : perspectives of surgical history, education, and clinical approaches
DO  - 10.1097/as9.0000000000000700
UR  - https://doi.org/10.1097/as9.0000000000000700
ER  - 

APA

A, F., A, C., D, S., P, D., A, V. R., R, G., J, B., H, W., AB, H., & M, K. (2026). Clinical Value of a 51-Neuroendocrine Tumor-Specific Gene Signature (NETest 2.0) for Management of Pancreatic and Small Bowel Neuroendocrine Tumors: A Prospective Study in a Consecutive Cohort of 82 Patients Considered for Surgery.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches. https://doi.org/10.1097/as9.0000000000000700

Source records